Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-08-26

Clinical Trial Update: Treatment of Orthostatic Intolerance in Patients With Parkinson's Disease Using Midodrine [NA]

View source ↗

Summary

Clinical trial update on using midodrine to treat orthostatic intolerance in Parkinson's disease; the trial status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Midodrine (Midodrine)

Snippet

Sponsor: Corporal Michael J. Crescenz VA Medical Center | Conditions: Orthostatic Intolerance, Parkinson's Disease | NA | Status: UNKNOWN